DMRA earnings: a negative outcome, -5.5%

On February 17, 2022, Damora Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -5.5% in the window around the event. It had already run -13.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.